Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Poynard

Showing results (281-290 of 324) with videos related to

Pageof 33
Sort By:
Drugs|January 1, 1989
A randomised controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosisD Lebrec, T Poynard, J Bernuau, et al.
The New England Journal of Medicine|June 1, 1995
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study GroupT Poynard, P Bedossa, M Chevallier, et al.
Journal of Viral Hepatitis|June 26, 2002
Fatigue in patients with chronic hepatitis CT Poynard, P Cacoub, V Ratziu, et al.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Pruritus and the hepatitis C virus. The MULTIVIRC Unit]H Dega, C Francès, N Dupin, et al.
Journal of Viral Hepatitis|April 14, 2006
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudineF Zoulim, T Poynard, F Degos, et al.
Alcoholism, Clinical and Experimental Research|December 1, 1989
Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patientsP Bedossa, T Poynard, A Abella, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc GroupY Benhamou, M Bochet, V Di Martino, et al.
Gastroenterologie Clinique Et Biologique|February 6, 2009
Discordance between results of biomarkers of fibrosis shows that it is at least a "ménage à deux"M Munteanu, P Lebray, J Massard, et al.
Gastroenterology|June 1, 1996
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisoloneP Mathurin, V Duchatelle, M J Ramond, et al.
Journal of Clinical Pathology|November 24, 1999
Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoringF Imbert-Bismut, F Charlotte, B Turlin, et al.
Pageof 33

Showing results (281-290 of 324) with videos related to

Sort By:
Pageof 33
Drugs|January 1, 1989
A randomised controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosisD Lebrec, T Poynard, J Bernuau, et al.
The New England Journal of Medicine|June 1, 1995
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study GroupT Poynard, P Bedossa, M Chevallier, et al.
Journal of Viral Hepatitis|June 26, 2002
Fatigue in patients with chronic hepatitis CT Poynard, P Cacoub, V Ratziu, et al.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Pruritus and the hepatitis C virus. The MULTIVIRC Unit]H Dega, C Francès, N Dupin, et al.
Journal of Viral Hepatitis|April 14, 2006
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudineF Zoulim, T Poynard, F Degos, et al.
Alcoholism, Clinical and Experimental Research|December 1, 1989
Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patientsP Bedossa, T Poynard, A Abella, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc GroupY Benhamou, M Bochet, V Di Martino, et al.
Gastroenterologie Clinique Et Biologique|February 6, 2009
Discordance between results of biomarkers of fibrosis shows that it is at least a "ménage à deux"M Munteanu, P Lebray, J Massard, et al.
Gastroenterology|June 1, 1996
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisoloneP Mathurin, V Duchatelle, M J Ramond, et al.
Journal of Clinical Pathology|November 24, 1999
Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoringF Imbert-Bismut, F Charlotte, B Turlin, et al.
Pageof 33